At airports, it's a common sight to see travelers dragging suitcases packed with health supplements from Japan or Germany. Why are so many people willing to spend extra money and risk customs checks just to bring home capsules from Japan, Germany, or even the US? This "cross-border health" trend is more than a personal choice; it reflects a mix of market factors driven by brand preference, price differences, and product uniqueness.

From the inception of a new drug to its market launch, the process demands astronomical investments, prolonged development timelines, and faces countless risks at every stage. For decades, pharmaceutical companies have struggled along this arduous path, with many promising drugs failing to reach patients. However, the rise of artificial intelligence (AI) is ushering in a transformative era, disrupting traditional drug development paradigms. AI not only streamlines R&D workflows but also reshapes the global landscape of capital and innovation competition.

Probiotics are like little soldiers in your body, always ready to help you digest. There are many different types of these beneficial bacteria, so finding the right kind for you can make a big difference in supporting your digestive health.

The growth of the overall global biotech pharmaceutical market is slowing down. Europe and the United States have entered a mature period, and global development in the overall biotech pharmaceutical industry market has slowed down in recent years.

The growth of the overall global biotech pharmaceutical market is slowing down. Europe and the United States have entered a mature period, and global development in the overall biotech pharmaceutical industry market has slowed down in recent years.

Bioeconomy has attracted widespread attention. Bioeconomy is an economic form based on biological resources and biotechnology and based on the market operation of biotechnology products.

The future development of the biotechnology industry will play an extremely important role in the maintenance of human life and health, the improvement of the quality of life, and the promotion of national economic development. In recent years, all countries in the world have actively promoted the biotechnology industry.

The growth of the overall global biotech pharmaceutical market is slowing down. Europe and the United States have entered a mature period, and global development in the overall biotech pharmaceutical industry market has slowed down in recent years.